(9-393) Evaluation of the Safety Profile and Cost Impact of Fixed-dose Subcutaneous Pertuzumab/trastuzumab/hyaluronidase-zzxf in HER2-positive Breast Cancer

Wednesday, December 7, 2022

8:30 AM – 9:30 AM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Oncology/Hematology

Co-Author(s): Frank Gentile, Khang Pham, Katerine Dumais, Damaal Walker

Primary Author(s)

Caleb Good, PharmD
PGY2 Oncology Pharmacy Resident
Memorial Cancer Institute, Florida